Conmed (CNMD) Tops Q1 EPS by 5c; Withdraws Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
CONMED Corporation Announces First Quarter 2020 Financial Results
April 29, 2020 4:05 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2020.
First Quarter 2020 Highlights
Sales of $214.0 million decreased 2.0% year over year as reported and 0.7% in constant currency. Acquisitions contributed approximately 290 basis points of growth. Domestic revenue increased 1.6% year over year. International revenue decreased 6.1% as reported and 3.4% in constant currency. Diluted net earnings per share (GAAP) were $0.20, compared to diluted net earnings per share of $0.04 in the first quarter of 2019. Adjusted diluted net... More